Targeted Mutation Testing – Sanger Sequencing (3500 Genetic Analyser)

A NATA accredited Sanger sequencing method is used for targeted mutation testing of single exons for the conditions specified in our other tests, including Familial Hemiplegic Migraine, Episodic Ataxia, Spinocerebellar Ataxia, Epilepsy, CADASIL and related neuromuscular conditions.

This approach is cost-effective for suspected specific genetic mutation based on prior data from family members.